Ginkgo Bioworks Holdings Inc vs Domino's Pizza, Inc. — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Domino's Pizza, Inc. trades at $355.78 (market cap $11.82B). The key difference: Domino's Pizza, Inc. is far larger — about 23.4× Ginkgo Bioworks Holdings Inc's market cap, and Domino's Pizza, Inc. pays a 2.23% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | DPZ | |
|---|---|---|
Market Cap | $505.73M | $11.82B |
Sector | Health | Consumer Cyclical |
52-Week High | $16.14 | $467.30 |
52-Week Low | $5.48 | $282.89 |
Enterprise Value | $607.68M | $16.78B |
Dividend Yield | — | 2.23% |
Trailing returns across standard periods
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →Domino's is a restaurant operator and franchiser with nearly 19,000 global stores across more than 90 international markets at the end of 2021. The firm generates revenue through the sales of pizza, wings, salads, and sandwiches at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's U.S. and Canadian restaurants. With roughly $17.7 billion in 2021 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Papa John's, and Little Caesars.
Read more on DPZ →